Viking Therapeutics Stock No-Brainer: Is It Worth Buying Below $35?
Viking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
A quick guide to reputable sources for index level data, plus tips on choosing datasets and validating their reliability for analysis.
24,978 articlesViking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
A new class of startups installing tiny data centers is testing home-based compute nodes to relieve grid pressure and...
A fresh look at why a trillion-dollar cloud leader could outpace Apple in AI. Learn the mechanics, risks, and how to ...
As 2025 earnings season unfolds, AvePoint faces a pivotal moment in cloud data governance and SaaS expansion. This gu...
When a heavyweight like SPGI outperforms in a quiet market, it often signals more than a single stock move. This piec...
A biotech growth stock has surged 70% this year as it heads into pivotal phase 3 data and regulatory steps. Here’s wh...
A major AI outage disrupted Claude, a popular chatbot used by crypto traders. This guide explains the outage, its pot...
As Nvidia continues to ride AI-driven demand, the 2027 earnings outlook blends growth in data centers, gaming resilie...
AI-driven data centers are fueling a power supercycle, pushing on-site generation and turbocharging turbine prices. G...
What the arcturus (arct) 2025 earnings report may reveal isn’t just about a single quarter. This guide breaks down th...
A bold AI experiment in Argentina aimed at reshaping public policy stumbled on human error and bad data. The fallout ...
When a Veeco director sells a large block, it sparks questions. This article explains what insider trades mean, how t...